Saebø Asgeir, Saebø Per-Christian, Griinari J Mikko, Shingfield Kevin J
Natural ASA, Hovdebygda, Norway.
Lipids. 2005 Aug;40(8):823-32. doi: 10.1007/s11745-005-1444-7.
The trans-10,cis-12 isomer of conjugated linoleic acid (CLA) decreases TAG accumulation in 3T3-L1 adipocytes, reduces lipid accretion in growing animals, and inhibits milk fat synthesis in lactating mammals. However, there is evidence to suggest that other FA may also exert antilipogenic effects. In the current experiment, the effects of geometric isomers of 10,12 CLA on milk fat synthesis were examined using four Holstein-British Friesian cows in a 4 x 4 Latin Square experiment with 14-d periods. Treatments consisted of abomasal infusions of skim milk, or skim milk containing trans-10,cis-12 CLA (T1), trans-10,trans-12 CLA (T2), or a mixture of predominantly 10,12 isomers containing (g/l00 g) trans-10,cis-12 (35.0), cis-10,trans-12 (23.2), trans-10,trans-12 (14.9), and cis-10,cis-12 (5.1). CLA supplements were prepared from purified ethyl linoleate and infused as nonesterified FA. Infusions were conducted over a 4-d period with a 10-d interval between treatments and targeted to deliver 4.5 g/d of 10,12 CLA isomers. Compared with the control, trans-10, trans-12 CLA had no effect (P> 0.05) on milk fat yield, whereas treatments T1 and T3 depressed (P < 0.05) milk fat content (19.8 and 22.9%, respectively) and decreased milk fat output (20.8 and 21.3%, respectively). Comparable reductions in milk fat synthesis to 4.14 and 1.80 g trans-10,cis-12/d supplied by treatments T1 and T3 indicate that other 10,12 geometric isomers of CLA have the potential to exert antilipogenic effects. The relative abundance of cis-10,trans-12 CLA in treatment T3 and the low transfer efficiency of this isomer into milk suggest that cis-10,trans-12 CLA was the active component..
共轭亚油酸(CLA)的反式-10,顺式-12异构体可减少3T3-L1脂肪细胞中的甘油三酯积累,降低生长动物的脂质蓄积,并抑制泌乳哺乳动物的乳脂肪合成。然而,有证据表明其他脂肪酸也可能具有抗脂肪生成作用。在当前实验中,采用4×4拉丁方实验设计,以14天为周期,使用四头荷斯坦-英国弗里生奶牛研究了10,12-CLA几何异构体对乳脂肪合成的影响。处理方式包括向皱胃灌注脱脂乳,或含有反式-10,顺式-12 CLA(T1)、反式-10,反式-12 CLA(T2)的脱脂乳,或主要含10,12异构体的混合物(每100克含反式-10,顺式-12(35.0)、顺式-10,反式-12(23.2)、反式-10,反式-12(14.9)和顺式-10,顺式-12(5.1))。CLA补充剂由纯化的亚油酸乙酯制备,并以非酯化脂肪酸形式灌注。在4天内进行灌注,处理之间间隔10天,目标是每天输送4.5克10,12-CLA异构体。与对照组相比,反式-10,反式-12 CLA对乳脂肪产量无影响(P>0.05),而处理T1和T3降低了(P<0.05)乳脂肪含量(分别为19.8%和22.9%)并减少了乳脂肪产量(分别为20.8%和21.3%)。处理T1和T3提供的反式-10,顺式-12/d分别降至4.14和1.80克,这表明CLA的其他10,12几何异构体具有发挥抗脂肪生成作用的潜力。处理T3中顺式-10,反式-12 CLA的相对丰度以及该异构体向乳中的低转移效率表明顺式-10,反式-12 CLA是活性成分。